IFG Advisory’s Emergent Biosolutions EBS Stock Holding History

IFG Advisory’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,248	Closed	-$208K	–	483
2021 Q1	$208K	Hold	2,248	–	–	0.03%	459
2020 Q4	$201K	Hold	2,248	–	–	0.03%	438
2020 Q3	$232K	Buy	+2,248	New	+$242K	0.04%	368
2019 Q2	–	Sell	-4,804	Closed	-$242K	–	347
2019 Q1	$242K	Hold	4,804	–	–	0.05%	295
2018 Q4	$284K	Sell	4,804 -24,871	-84%	-$1.6M	0.07%	250
2018 Q3	$1.95M	Buy	29,675 +1,514	+5%	+$88.3K	0.37%	59
2018 Q2	$1.42M	Buy	28,161 +9,963	+55%	+$519K	0.29%	79
2018 Q1	$958K	Sell	18,198 -3,740	-17%	-$186K	0.21%	112
2017 Q4	$1.02M	Buy	+21,938	New	+$923K	0.23%	102

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IFG Advisory's EBS Position: Q2 2021 in Review

IFG Advisory sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 2,248 shares — an estimated $208K sold.

IFG Advisory first reported a position in EBS in Q4 2017 and held it in 9 quarters. The position peaked at $1.95M in Q3 2018. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

IFG Advisory reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
IFG Advisory sold 2,248 Emergent Biosolutions shares in Q2 2021, an estimated $208K.
IFG Advisory first reported a position in Emergent Biosolutions in Q4 2017 and held it in 9 quarters.
IFG Advisory's Emergent Biosolutions position peaked at $1.95M in Q3 2018.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on IFG Advisory's 13F filing for Q2 2021, filed 21 Jul 2021.